Expression of protein kinase C isoforms in cancerous breast tissue and adjacent normal breast tissue

Chinese Journal of Physiology

Volumn 55, Issue 1, 2012, Pages 55-61

  Lin, Yueh Min ^a   Su, Cheng Chuan ^b,c   Su, Wei Wen ^a   Hwang, Jin Ming ^d   Hsu, Hsi Hsien ^e   Tsai, Chang Hai ^f   Wang, Yen Chu ^d   Tsai, Fuu Jen ^g   Huang, Chih Yang ^f,g,h   Liu, Jer Yuh ^h,i   Chen, Li Mien ^j,k  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g Graduate Institute of Chinese Medical Science   (China)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^j TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^k CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

more..

Author keywords

Human breast cancer; Protein kinase C (PKC)

Indexed keywords

MESSENGER RNA; MYELOID ZINC FINGER 1 PROTEIN; PROTEIN KINASE C ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR MZF 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HS57BT; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL STRAIN MDA MB 468; CELL STRAIN SKBR3; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84455163097     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2012.AMM118     Document Type: Article

References (22)

1. Ainbinder, E., Bergelson, S. and Daniel, V. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3- methylcholanthrene. Recept. Signal Transduct. 7: 279-289, 1997.
2. Akimoto, K., Mizuno, K., Osada, S., Hirai, S., Tanuma, S., Suzuki, K. and Ohno, S. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J. Biol. Chem. 269: 12677-12683, 1994.
3. Ali, S., Al-Sukhun, S., El-Rayes, B.F., Sarkar, F.H., Heilbrun, L.K. and Philip, P.A. Protein kinases C isozymes are differentially expressed in human breast carcinomas. Life Sci. 84: 766-771, 2009.
4. Assoka, Y., Nakamura, S.I., Yoshida, K. and Nishizuka, Y. Protein kinase C, calcium and phospholipid degradation. Trends Biochem. Sci. 17: 414-417, 1992.
5. Balleste, R., Furth, M.E. and Rosen, O.M. Phobol ester and protein kinase C mediated phosphorylation of cellular kirsten ras gene product. J. Biol. Chem. 262: 2688-2695, 1987.
6. Bamberger, A.M., Bamberger, C.M., Wald, M., Kratzmeier, M. and Schulte, H.M. Protein kinase C (PKC) isoenzyme expression pattern as indicator of proliferative activity in uterine tumor cells. Mol. Cell. Endocrinol. 123: 81-88, 1996.
7. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72: 248-254, 1976.
8. Gould, K.L., Woodgett, J.R., Cooper, J.A., Buss, J.E., Shalloway, D. and Hunter, T. Protein kinase C phosphoylation pp60src at novel site. Cell 42: 849-857, 1985.
9. Housey, G.M., Johnson, M.D., Hsiao, W.L., O'Brian, C.A., Murphy, J.P, Kirschmeier, P. and Weinstein, I.B. Overproduction of protein kinase C causes disordered growth control in rat fibroblast. Cell 52: 343-354, 1988.
10. Hsieh, Y.H., Wu, T.T., Huang, C.Y., Hsieh, Y.S., Hwang, J.M. and Liu, J.Y. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res. 67: 4320-7432, 2007.
11. Krauss, R., Housey, G., Johnson, M. and Weinstein, I.B. Disturbances in growth control and Gene expression in a C3H10T1/2 cell line that stably overproduces protein kinase C. Oncogene 4: 991-998, 1989.
12. Murray, N.R. and Frield, A.P. Atypical protein kinase C iota protects human leukemia cells against drug apoptosis. J. Biol. Chem. 272: 27521-27524, 1997.
13. Newton, A.C. Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 270: 28495-28498, 1995.
14. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
15. Nishizuka, Y. Protein kinase C and lipid signaling for sustained cellular responses. Faseb J. 9: 484-496, 1995.
16. O'Brian, C.A., Vogel, V.G., Singletary, S.E. and Ward, N.E. Elevation protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49: 3215-3217, 1989.
17. Ohno, S. and Nishizuka, Y. Protein kinase C isotypes and their specific functions: prologue. J. Biochem. 132: 509-511, 2002.
18. Rakha, E.A., Reis-Filho, J.S. and Ellis, I.O. Combinatorial biomarker expression in breast cancer. Breast Cancer Res. Treat. 120: 293-308, 2010.
19. Serlachius, E., Svennilson, J., Schalling, M. and Aperia, A. Protein kinase C in the developing kidney: Isoform expression and effects of ceramide and PKC inhibitors. Kidney Int. 52: 901-910, 1997.
20. Suzuki, A., Akimoto, K., and Ohno, S. Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms. J. Biochem. 133: 9-16, 2003.
21. Tan, M., Li, P., Sun, M., Yin, G. and Yu, D. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene 25: 3286-3295, 2006.
22. Ways, D.K., Kukoly, C.A., deVente, J., Hooker, J.L., Bryant, W.O., Posekany, K.J., Fletcher, D.J., Cook, P.P. and Parker, P.J. MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95: 1906-1915, 1995.